ALERT

Due to the overwhelming surge in COVID-19 cases and the strain it has placed on health care capacity in the communities we serve, the Idaho Department of Health and Welfare has activated crisis standards of care statewide. We are open and available to see patients, but you may experience delays at our ERs, hospitals, and clinics. We appreciate your patience. Access more info on COVID testing, vaccination, visitor policy, hospitalization data, and FAQs.

toggle mobile menu Menu
toggle search menu

Site Navigation

Supplemental

Menu

St. Luke’s Cancer Research Program, Susan Hill’s Story

Susan's Story

Thanks to cancer research, Susan Hill was here to celebrate her 50th wedding anniversary. She’s been able to watch her granddaughters grown up, and she’s become a mentor and friend to people with cancer all across the country. Susan has primary myelofibrosis (MF). It’s a rare blood cancer—only about 18,000 people are diagnosed with it each year in the United States. Today MF is considered a chronic, progressive, yet manageable disease, but when Sue was diagnosed in 2001, MF wasn’t even classified as a cancer—and it was considered terminal. That’s how far we’ve come—thanks to cancer research.